- Treatment trial
- Adaptive-design protocol
- Enrolled 1,063 participants over 58 days
- 68 sites in 10 countries globally
Pandemic Experience Means Expert Guidance
Michelle Atallah, Director, Business Development, discusses how FHI Clinical quickly adopted new ways to enable fully remote site monitoring in some of our ongoing studies.
FHI Clinical continues to work with researchers to identify and initiate global sites with the most appropriate capabilities and patient population for study-specific protocols. While the COVID-19 pandemic and its aftermath have presented unique challenges this past year, there are many lessons learned that we can apply to all of our future studies for a larger impact and gained efficiencies.